Patients with juvenile idiopathic arthritis on TNF inhibitors exposed to COVID-19 family members
| Errataetall: |
CommentOn: Semin Arthritis Rheum. 2020 Aug;50(4):564-570. - PMID 32425260 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:50 |
|---|---|
| Enthalten in: |
Seminars in arthritis and rheumatism - 50(2020), 6 vom: 30. Dez., Seite 1214-1215 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Marino, Achille [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antirheumatic Agents |
|---|
| Anmerkungen: |
Date Completed 17.12.2020 Date Revised 19.02.2021 published: Print-Electronic CommentOn: Semin Arthritis Rheum. 2020 Aug;50(4):564-570. - PMID 32425260 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.semarthrit.2020.09.012 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM316288322 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM316288322 | ||
| 003 | DE-627 | ||
| 005 | 20231225160748.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.semarthrit.2020.09.012 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1054.xml |
| 035 | |a (DE-627)NLM316288322 | ||
| 035 | |a (NLM)33059294 | ||
| 035 | |a (PII)S0049-0172(20)30262-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Marino, Achille |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Patients with juvenile idiopathic arthritis on TNF inhibitors exposed to COVID-19 family members |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.12.2020 | ||
| 500 | |a Date Revised 19.02.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Semin Arthritis Rheum. 2020 Aug;50(4):564-570. - PMID 32425260 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Juvenile idiopathic arthritis | |
| 650 | 4 | |a Rheumatic disease | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a TNF inhibitor | |
| 650 | 7 | |a Antirheumatic Agents |2 NLM | |
| 650 | 7 | |a Biological Products |2 NLM | |
| 650 | 7 | |a Tumor Necrosis Factor Inhibitors |2 NLM | |
| 700 | 1 | |a Romano, Micol |e verfasserin |4 aut | |
| 700 | 1 | |a Gattinara, Maurizio |e verfasserin |4 aut | |
| 700 | 1 | |a Cimaz, Rolando |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Seminars in arthritis and rheumatism |d 1971 |g 50(2020), 6 vom: 30. Dez., Seite 1214-1215 |w (DE-627)NLM000215643 |x 1532-866X |7 nnns |
| 773 | 1 | 8 | |g volume:50 |g year:2020 |g number:6 |g day:30 |g month:12 |g pages:1214-1215 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.semarthrit.2020.09.012 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 50 |j 2020 |e 6 |b 30 |c 12 |h 1214-1215 | ||